Dual effects of 3,4-methylenedioxymethamphetamine (ecstasy) on survival and apoptosis of primary hippocampal neurons

被引:0
|
作者
Abolfazl Azami
Parichehr Pasbakhsh
Mohammad Akbari
Mohammad Barbarestani
Mohammadhosein Ghahremani
Mohammadali Shokrgozar
Ali Mandegary
Amir Kiani
Gholamreza Hassanzadeh
机构
[1] School of Pharmacy,Kermanshah University of Medical Scences
[2] Department of Anatomy,School of Medicine,Tehran University of Medical Sciences
[3] National Cell Bank of Iran,Pasteur Institute of Iran
[4] Department of Toxicology-Pharmacology,Faculty of Pharmacy,Tehran University of Medical Sciences
关键词
3,4-methylenedioxymethamphetamine; ecstasy; apoptosis; N-methyl-D-aspartate; neuronal culture;
D O I
暂无
中图分类号
R363 [病理生理学];
学科分类号
100104 ;
摘要
BACKGROUND: 3, 4-methylenedioxymethamphetamine (MDMA, also known as "ecstasy") hasbeen shown to exhibit neurotoxic effects on the hippocampus. However, exposure to sub-lethalinsults of MDMA has been reported to result in neuroprotection.OBJECTIVE: To investigate the effects of MDMA on hippocampal neuronal viability, caspase-3activity, and mRNA expression of the N-methyl-D-aspartate (NMDA) receptor 2B (NR2B) subunit.DESIGN, TIME AND SETTING: A cytological, in vitro experiment was performed at the Departmentof Anatomy, School of Medicine, and Department of Toxicology-Pharmacology, Faculty of PharmacyTehran University of Medical Sciences in 2008.MATERIALS: MDMA was extracted from ecstasy tablets, which were kindly supplied by thePharmacology-Toxicology Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Iran.METHODS: Hippocampal neurons were isolated from Wistar rats at gestational day 18. Followingprimary culture, hippocampal neuronal viability was detected by MTT assay. Varying concentrationsof MDMA (100 5 000 μmol/L) were used to determine lethal concentration 50 (LC50), which wasaround 1 500 μmol/L. Five concentrations of MDMA below 1 500 μmol/L (100, 200, 400, 800, and1 050 μmol/L) were used for the remaining experiments. After 24 hours of MDMA treatment,NR2B mRNA expression was detected by RT-PCR, and caspase-3 relative activity was determinedby colorimetric assay.MAIN OUTCOME MEASURES: Hippocampal neuronal viability, caspase-3 activity, andNR2B mRNA expression.RESULTS: MDMA-induced neurotoxicity in hippocampal neuronal cultures was dose-dependent. Inhigh concentrations (1 000-5 000 μmol/L) of MDMA, neuronal viability was decreased. However,with a 500 μmol/L dose of MDMA, neuronal viability was significantly increased (P < 0.01). Lowconcentrations of MDMA (200 and 400 μmol/L) significantly decreased caspase-3 activity (P < 0.01),whereas high concentrations of MDMA significantly increased caspase-3 activity (P < 0.01). NR2Bsubunit mRNA expression was not significantly altered after 100 1 050 μmol/L MDMA exposure.CONCLUSION: MDMA exhibits dual effects on hippocampal neuronal viability and caspase-3activitv. These effects are independent from NR2B subunit expression levels.
引用
收藏
页码:1068 / 1072
页数:5
相关论文
共 50 条
  • [31] Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram
    Matthias E Liechti
    Christine Baumann
    Alex Gamma
    Franz X Vollenweider
    Neuropsychopharmacology, 2000, 22 : 513 - 521
  • [32] Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram
    Liechti, ME
    Baumann, C
    Gamma, A
    Vollenweider, FX
    NEUROPSYCHOPHARMACOLOGY, 2000, 22 (05) : 513 - 521
  • [33] 3,4-methylenedioxymethamphetamine ('ecstasy'): Its long-term emotional and cognitive effects, and serotonin depletion
    Molero-Chamizo, A
    REVISTA DE NEUROLOGIA, 2005, 41 (02) : 108 - 114
  • [34] Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine ("Ecstasy") self-administration
    Reveron, Maria Elena
    Maier, Esther Y.
    Duvauchelle, Christine L.
    BEHAVIOURAL BRAIN RESEARCH, 2010, 207 (02) : 500 - 507
  • [35] Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA)
    Curry, Daniel W.
    Berro, Lais F.
    Belkoff, Andie R.
    Sulima, Agnieszka
    Rice, Kenner C.
    Howell, Leonard L.
    NEUROPHARMACOLOGY, 2019, 151 : 13 - 20
  • [36] 3,4-Methylenedioxymethamphetamine (Ecstasy) Decreases Inflammation and Airway Reactivity in a Murine Model of Asthma
    Stankevicius, Daniel
    Ferraz-de-Paula, Viviane
    Ribeiro, Alison
    Pinheiro, Milena Lobao
    Ligeiro de Oliveira, Ana P.
    Damazo, Amilcar S.
    Lapachinske, Silvio F.
    Moreau, Regina L. M.
    de Lima, Wothan Tavares
    Palermo-Neto, Joao
    NEUROIMMUNOMODULATION, 2012, 19 (04) : 209 - 219
  • [37] Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy)
    Movassaghi, Shabnam
    Sharifi, Zahra Nadia
    Mohammadzadeh, Farzaneh
    Soleimani, Mansooreh
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2013, 16 (08) : 922 - 927
  • [38] Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy) in conscious rabbits
    Pedersen, NP
    Blessing, WW
    JOURNAL OF NEUROSCIENCE, 2001, 21 (21) : 8648 - 8654
  • [39] Cannabis and ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users
    Parrott, A. C.
    Milani, R. M.
    Gouzoulis-Mayfrank, E.
    Daumann, J.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (08) : 959 - 968
  • [40] 3,4-methylenedioxymethamphetamine (mdma): A review
    O’Leary G.
    Nargiso J.
    Weiss R.D.
    Current Psychiatry Reports, 2001, 3 (6) : 477 - 483